Global Bio Surgical Agents Market, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agent, Surgical Sealants and Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynecological Surgery, Thoracic Surgery, Urological Surgery) – Industry Trends and Forecast to 2029.
Bio Surgical Agents Market Analysis and Size
According to the World Population Prospect, 2022, there will be 771 million people aged 65 and above, with this number expected to rise to 994 million by 2030 and 1.6 billion by 2050. Thus, as the geriatric population grows, so does the risk of numerous health consequences, such as increased incidences of orthopaedic and neurological problems, which can lead to biosurgery for treatment and thus drive market growth for bio surgical agents.
Data Bridge Market Research analyses that the bio surgical agents market which was USD 12.2 billion in 2021, would rocket up to USD 21.94 billion by 2029, and is expected to undergo a CAGR of 7.61% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bio Surgical Agents Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agent, Surgical Sealants and Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynecological Surgery, Thoracic Surgery, Urological Surgery)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Medtronic (Ireland), B. Braun SE (Germany), Stryker (U.S.), Brainlab AG (Germany), Integra LifeSciences (U.S.), Scopis GmbH (Germany), Boston Scientific Corporation (U.S.), Elekta (Sweden), Cyberonics, Inc. (U.S.), Micromar Ind. e Com. LTDA (Spain), Neuros Medical (U.S.), SPR Therapeutics (U.S.), St. Jude Children's Research Hospital (U.S.), Synapse Biomedical Inc. (U.S.), KARL STORZ (Germany), Abbott (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Biosurgery is a medical procedure that involves the use of natural, synthetic or semi-synthetic materials to seal surgical incisions and wounds. It is frequently used to stop uncontrollable bleeding, provide adhesion for sealing wounds or tissues, and mend broken bones and tissues. Typically, biosurgeries are carried out using a variety of hemostatic, sealant, soft tissue healing, bone graft replacement, adhesion prevention, and staple line reinforcing materials.
Bio Surgical Agents Market Dynamics
Drivers
- Increasing volume of surgeries and growing prevalence of severe trauma injuries
Adhesion formation is a serious post-operative complication that frequently necessitates additional procedures to treat affected individuals. Post-operative adhesion formation causes significant abdominal discomfort, infertility in women after gynaecological surgery, and physical disability in patients after neurological surgery. The need for solutions like adhesion barriers is growing in the market due to the negative consequences that post-surgery adhesion formation on patients.
- Expanding use of minimally invasive procedures
The market's expansion is primarily being fuelled by factors such as the rising prevalence of surgeries, particularly sports-related and trauma surgeries, the rising demand for technologically advanced surgical procedures, and the expanding use of minimally invasive procedures globally.
Opportunities
- Growing adoption of advanced bio surgery products in emerging markets
The use of bio surgery products is spreading in developing nations, particularly in the Asia-Pacific region, Latin America, the Middle East, and Africa. Players in the bio surgical agents market could have a lot of growth potential in the upcoming years in nations like China, India, and Brazil. This is due to the markets in these nations being marked by a sizable patient base for the target indications (such as cardiovascular, orthopaedic, general/abdominal, and gynaecological disorders), rising health awareness, growing healthcare expenditure, rising medical tourism, and quickly developing healthcare infrastructure.
Restraints/Challenges
- High price of bio surgery products and the rising cost of surgical procedures
On the other hand, the high cost, coupled with the unfavourable reimbursement scenario for these products in emerging countries, makes them unaffordable for a large section of the target patient population will obstruct the market's growth rate.
This bio surgical agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bio surgical agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Bio Surgical Agents Market
Hospitals became high-risk areas because of the rising COVID-19 prevalence, especially for patients with chronic illnesses. As a result, non-critical procedures like elective surgeries were either abandoned or delayed during the first and second quarters of 2020, which led to a significant drop in the overall volume of elective surgical procedures carried out. As a result, 2020 saw a substantial fall in the market for items used in biosurgery. Elective surgical operations were further deprioritized by COVID-19's second wave. Additionally, restrictions and bans on medical treatments and elective surgeries have been enacted by governments all over the world.
Recent Development
- In February 2020, Baxter announced that the Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip had received 510(k) clearance from the US FDA. The product, a staple line reinforcing agent, is suggested for reducing bleeding during other surgical operations, including bariatric surgery.
- In February 2020, AmnioExcel Plus Placental Allograft Membrane was launched by Integra LifeSciences Holdings Corp. for use in soft tissue repair.
- In October 2020, The O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, ready-to-use cervical and lumbar spacers for allograft surgeries, were announced by Orthofix Medical Inc. (US).
- In December 2019, The next-generation sealant product, VISTASEAL Fibrin Sealant (Human), which aids surgeons in controlling bleeding during surgery, was announced by Johnson & Johnson.
Global Bio Surgical Agents Market Scope
The bio surgical agents market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Bone Graft Substitutes
- Demineralized bone matrix
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Other Bone-Graft Substitutes
- Soft-tissue attachments
- Synthetic meshes
- Biological meshes
- Allografts
- Xenografts
- Hemostatic agents
- Thrombin-based hemostatic agents
- Oxidized regenerated cellulose-based hemostatic agents
- Combination hemostatic agents
- Surgical sealants and adhesives
- Natural/Biological Sealants and Adhesives
- Natural/Biological Sealants and Adhesives, Type
- Fibrin Sealants
- Collagen-Based Sealants
- Gelatin-Based Sealants
- Albumin-Based Sealants
- Other Natural/Biological Sealants
- Natural/Biological Sealants and Adhesives, Origin
- Human Blood-Based Sealants and Adhesives
- Animal-Based Sealants and Adhesives
- Synthetic and Semi-Synthetic Sealants and Adhesives
- Peg Hydrogels
- Cyanoacrylate-Based Sealants and Adhesives
- Urethane-Based Sealants and Adhesives
- Other Synthetic and Semi-Synthetic Sealants and Adhesives
- Adhesion Barriers
- Synthetic Adhesion Barriers
- Hyaluronic Acid-Based Adhesion Barriers
- Regenerated Cellulose-Based Adhesion Barriers
- Peg-Based Adhesion Barriers
- Other Synthetic Adhesion Barriers
- Natural Adhesion Barriers
- Collagen and Protein Adhesion Barriers
- Fibrin-Based Adhesion Barriers
- Staple-Line Reinforcement Agents
Application
- General Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Neurological Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Thoracic Surgery
- Urological Surgery
Bio Surgical Agents Market Regional Analysis/Insights
The bio surgical agents market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the bio surgical agents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bio surgical agents market due to the largest market size. It is because of the presence of well-developed healthcare system.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Bio Surgical Agents Market Share Analysis
The bio surgical agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bio surgical agents market.
Some of the major players operating in the bio surgical agents market are:
- Medtronic (Ireland)
- B. Braun SE (Germany)
- Stryker (U.S.)
- Brainlab AG (Germany)
- Integra LifeSciences (U.S.)
- Scopis GmbH (Germany)
- Boston Scientific Corporation (U.S.)
- Elekta (Sweden)
- Cyberonics, Inc. (U.S.)
- Micromar Ind. e Com. LTDA (Spain)
- Neuros Medical (U.S.)
- SPR Therapeutics (U.S.)
- St. Jude Children's Research Hospital (U.S.)
- Synapse Biomedical Inc. (U.S.)
- KARL STORZ (Germany)
- Abbott (U.S.)
SKU-